- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Gepants for Migraine Prevention: A Perfect Fit for Primary Care
Episode 14 of the Patient Care Online Primary Viewpoints podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.
The Primary Viewpoints podcast features informative conversations with health care experts, opinion leaders, and practicing physicians, about what impacts primary care medicine today.
In episode 14, headache specialist Dr Peter McAllister discusses the first FDA-approved migraine-specific oral preventive treatments in the gepant class and the role these medications may play in treatment of migraine in primary care settings.
Peter McAllister, MD, is medical director of the New England Institute for Neurology and Headache and chief medical officer of the Chief Medical Officer, New England Institute for Clinical Research, both located in Stamford, CT.
Click here to subscribe to the Primary Viewpoints podcast. Be sure to leave a rating and review for the show. Thanks for listening!
